Ariadne Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$824K Buy
3,373
+200
+6% +$46.6K 0.37% 61
2025
Q4
$776K Sell
3,173
-245
-7% -$48.4K 0.32% 70
2025
Q3
$667K Buy
3,418
+30
+0.9% +$5.14K 0.3% 74
2025
Q2
$591K Buy
3,388
+562
+20% +$86.4K 0.28% 77
2025
Q1
$436K Sell
2,826
-440
-13% -$68.8K 0.23% 97
2024
Q4
$504K Buy
3,266
+1,233
+61% +$191K 0.23% 85
2024
Q3
$319K Buy
2,033
+99
+5% +$15.8K 0.17% 122
2024
Q2
$283K Buy
+1,934
New +$288K 0.22% 101

Other funds holding JNJ

Ariadne Wealth Management's JNJ Position: Q1 2026 in Review

Ariadne Wealth Management increased its Johnson & Johnson (JNJ) stake by 6.3% in Q1 2026, buying an estimated $46.6K and bringing the position to 3,373 shares worth $824K. The position accounts for 0.37% of the portfolio, ranked #61.

Ariadne Wealth Management first reported a position in JNJ in Q2 2024 and has held it in 8 quarters since. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Ariadne Wealth Management held 3,373 shares of Johnson & Johnson worth $824K as of Q1 2026.
  • Ariadne Wealth Management bought 200 Johnson & Johnson shares in Q1 2026, an estimated $46.6K.
  • Johnson & Johnson made up 0.37% of Ariadne Wealth Management's portfolio in Q1 2026, its #61 holding.
  • Ariadne Wealth Management first reported a position in Johnson & Johnson in Q2 2024 and has held it in 8 quarters since.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Ariadne Wealth Management's 13F filing for Q1 2026, filed 18 May 2026.